Dysregulation of the TGFBI gene is involved in the oncogenic activity of the nonsense mutation of hepatitis B virus surface gene sW182*

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 1080-1087

  Jiang, Shih Sheng ^a   Huang, Shiu Feng ^a,b   Huang, Min Syuan ^a   Chen, Yng Tay ^a,c   Jhong, Hsiang Ju ^a   Chang, Il Chi ^a   Chen, Ya Ting ^a   Chang, Jer Wei ^a   Chen, Wen Ling ^a   Lee, Wei Chen ^b   Chen, Miin Fu ^b   Yeh, Chau Ting ^b   Matsuura, Isao ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclin D1; HBV PreS S gene; HCC; Hepatocarcinogenesis; Nonsense mutation; TGFBI

Indexed keywords

CYCLIN D1; HEPATITIS B SURFACE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CARCINOGENICITY; CELL CYCLE REGULATION; CELL MUTANT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; MITOSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; STOP CODON; TUMOR GROWTH; VIRUS GENE;

CYCLIN D1; HBV PRES/S GENE; HCC; HEPATOCARCINOGENESIS; NONSENSE MUTATION; TGFBI;

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE; CODON, NONSENSE; CYCLIN D1; DNA METHYLATION; DNA REPAIR; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GENOMIC INSTABILITY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84898795185     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.03.007     Document Type: Article

References (34)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Breasley R.P. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1956.
3. Feitelson M. Hepatitis B virus infection and primary hepatocellular carcinoma. Clin. Microbiol. Rev. 1992, 5:275-301.
4. Robinson W.S. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med. 1994, 45:297-323.
5. Kekulé A.S., Lauer U., Meyer M., Caselmann W.H., Hofschneider P.H., Koshy R. The pre-S2/S region of integrated hepatitis B virus encodes a transcriptional transactivator. Nature 1990, 343:457-461.
6. Lauer U., Weiss L., Hofschneider P.H., Kekulé A.S. The hepatitis B virus pre-S/S(t) transactivator is generated by 3' truncations within a defined region of the S gene. J. Virol. 1992, 66:5284-5289.
7. Lai M.W., Huang S.F., Hsu C.W., Chang M.H., Liaw Y.F., Yeh C.T. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy. Antivir. Ther. 2009, 14:249-261.
8. Yeh C.T., Chen T., Hsu C.W., Chen Y.C., Lai M.W., Liang K.H., Chen T.C. Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer 2011, 11:398. 10.1186/1471-2407-11-398.
9. Huang S., Chen Y., Lee W., Chang I., Chiu Y., Chang Y., Tu H., Yuh C., Matsuura I., Shih L., Lai M., Wu H.H., Chen M., Yeh C. Identification of transforming hepatitis B virus S gene nonsense mutations derived from freely replicative viruses in hepatocellular carcinoma. PLoS One 2014, 10.1371/journal.pone.0089753.
10. Lee S.A., Kim K., Kim H., Kim B.J. Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases. J. Hepatol. 2012, 56:63-69.
11. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992, 11:511-522.
12. Klintworth G.K. The molecular genetics of the corneal dystrophies - current status. Front. Biosci. 2003, 1:687-713.
13. Zhao Y., El-Cabry M., Hei T.K. Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells. Mol. Carcinog. 2006, 45:84-92.
14. Calaf G., Echiburu-Chau C., Zhao Y.L., Hei T.K. BigH3 protein expression as a marker for breast cancer. Int. J. Mol. Med. 2008, 21:561-568.
15. Ween M.P., Oehler M.K., Ricciardelli C. Transforming growth factor-beta-induced protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer. Int. J. Cancer 2012, 13:10461-10477.
16. Zhang Y., Wen G., Shao G., Wang G., Lin C., Fang H., Balajee A.S., Bhagat G., Hei T.K., Zhao Y. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2007, 69:37-44.
17. Lin B., Madan A., Yoon J.G., Fang X., Yan X., Kim T.K., Hwang D., Hood L., Folz G. Massively parallel signature sequencing and bioinformatics analysis identifies upregulation of TGFBI and SOX4 in human glioblastoma. PLoS One 2010, 5:e10210.
18. Ma C., Rong Y., Radiloff D.R., Datto M.B., Centeno B., Bao S., Chen A.W., Lin F., Jiang S., Yeatman T.J., Wang X.F. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 2008, 22:308-321.
19. Zajchowski D.A., Bartholdi M.F., Gong Y., Webster L., Liu H.L., Munishkin A., Beauheim C., Harvey S., Ethier S.P., Johnson P.H. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001, 61:5168-5178.
20. Matsuura I., Lai C.Y., Chiang K.N. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-β-mediated cancer cell invasiveness. Biochem. J. 2010, 426:327-335.
21. Jiang S.S., Fang W.T., Hou Y.H., Huang S.F., Yen B.L., Chang J.L., Li S.M., Liu H.P., Liu Y.L., Huang C.T., Li Y.W., Jang T.H., Chan S.H., Yang S.J., Hsiung C.A., Wu C.W., Wang L.H. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin. Cancer Res. 2010, 16:4363-4373.
22. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
23. Boyault S., Rickman D.S., de Reyniès A., Balabaud C., Rebouissou S., Jeannot E., Hérault A., Saric J., Belghiti J., Franco D., Bioulac-Sage P., Laurent-Puig P., Zucman-Rossi J. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007, 45:42-52.
24. Shao G., Berenguer J., Borczuk A.C., Powell C.A., Hei T.K., Zhao Y. Epigenetic inactivation of betaig-h3 gene in human cancer cells. Cancer Res. 2006, 66:4566-4573.
25. Ahmed A.A., Mills A.D., Ibrahim A.E., Temple J., Blenkiron C., Vias M., Massie C.E., Iyer N.G., McGeoch A., Crawford R., Nicke B., Downward J., Swanton C., Bell S.D., Earl H.M., Laskey R.A., Caldas C., Brenton J.D. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 2007, 12:514-527.
26. Shah J.N., Shao G., Hei T.K., Zhao Y. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. BMC Cancer 2008, 8:284. 10.1186/1471-2407-8-284.
27. Kang S., Dong S.M., Park N.H. Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer. Gynecol. Oncol. 2010, 118:58-63.
28. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Hara E., Tenen D.G., Hozumi N., Oikawa T. Site specific DNA methylation by a complex of PU.1 and DNmt3a/b. Oncogene 2006, 25:2477-2488.
29. Tachibana M., Matsumura Y., Fukuda M., Kimura H., Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J. 2008, 27:2681-2690.
30. Jung J.K., Arora P., Pagano J.S., Jang K.L. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007, 67:5771-5778.
31. Zhu Y.Z., Zhu R., Shi L.G., Mao Y., Zheng G.J., Chen Q., Zhu H.G. Hepatitis B virus X protein promotes hypermethylation of p16 (INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Exp. Mol. Pathol. 2010, 89:268-275.
32. Gazin C., Wajapeyee N., Gobeil S., Virbasius C.M., Green M.R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007, 449:1073-1078.
33. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994, 369:669-671.
34. The American Joint Committee of Cancer Cancer Staining Manual 2002, Springer, Heidelberg, (Part III, Liver). sixth ed.